Ozempic, Wegovy Shortage Is Officially Over



(MedPage Today) — The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday.
The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand…



Source link : https://www.medpagetoday.com/endocrinology/diabetes/114324

Author :

Publish date : 2025-02-21 18:36:36

Copyright for syndicated content belongs to the linked Source.
Exit mobile version